Genomics in Scotland strategy: business and regulatory impact assessment

Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).


8. Consumer Assessment

The strategy, which aims to improve access to genomic testing for patients in Scotland, will not have a negative impact on consumers.

Contact

Email: holly.ennis@gov.scot

Back to top